US Stock MarketDetailed Quotes

Gain Therapeutics (GANX)

Watchlist
  • 2.050
  • -0.090-4.21%
Close Apr 16 15:59 ET
  • 2.070
  • +0.020+0.98%
Post 20:01 ET
87.10MMarket Cap-3.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gain Therapeutics (GANX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.06%18.71M
34.07%4.47M
7.33%4.79M
-37.80%5.09M
-0.19%4.37M
-8.78%20.35M
-24.42%3.33M
-8.72%4.46M
5.84%8.18M
-17.17%4.38M
Selling and administrative expenses
-11.11%8.5M
0.59%2.12M
5.39%1.94M
-37.77%2.33M
12.91%2.11M
-11.38%9.56M
3.59%2.11M
-27.02%1.84M
0.05%3.75M
-24.98%1.87M
-General and administrative expense
-11.11%8.5M
0.59%2.12M
5.39%1.94M
-37.77%2.33M
12.91%2.11M
-11.38%9.56M
3.59%2.11M
-27.02%1.84M
0.05%3.75M
-24.98%1.87M
Research and development costs
-5.36%10.21M
91.65%2.35M
8.69%2.85M
-37.83%2.76M
-9.97%2.26M
-6.33%10.79M
-48.41%1.22M
10.74%2.62M
11.28%4.44M
-10.19%2.51M
Operating profit
8.06%-18.71M
-34.07%-4.47M
-7.33%-4.79M
37.80%-5.09M
0.19%-4.37M
8.55%-20.35M
24.42%-3.33M
8.72%-4.46M
-5.84%-8.18M
16.29%-4.38M
Net non-operating interest income expense
-31.56%244.39K
60.71%83.34K
-25.93%78.07K
-49.64%42.57K
-64.95%40.41K
-27.75%357.1K
-51.20%51.86K
-0.56%105.41K
-34.94%84.53K
-24.16%115.3K
Non-operating interest income
-31.56%244.39K
----
----
----
----
-27.75%357.1K
----
----
----
----
Total other finance cost
----
----
25.93%-78.07K
49.64%-42.57K
64.95%-40.41K
----
----
0.56%-105.41K
34.94%-84.53K
24.16%-115.3K
Other net income (expense)
-799.86%-833.67K
-638.02%-84.78K
77.40%-27.38K
-1,324.92%-620.92K
-137.52%-100.59K
127.74%119.12K
103.86%15.76K
-247.37%-121.14K
27.61%-43.58K
725.73%268.08K
Gain on sale of security
-799.86%-833.67K
-638.02%-84.78K
77.40%-27.38K
-1,324.92%-620.92K
-137.52%-100.59K
127.74%119.12K
103.86%15.76K
-247.37%-121.14K
27.61%-43.58K
725.73%268.08K
Income before tax
2.89%-19.3M
-36.89%-4.47M
-5.82%-4.74M
30.39%-5.67M
-10.90%-4.43M
10.43%-19.87M
30.70%-3.26M
4.73%-4.47M
-6.27%-8.14M
21.99%-3.99M
Income tax
60.41%861.12K
-86.11%70.12K
4,896.25%549.29K
11,579.49%141.21K
405.73%100.51K
577.16%536.82K
3,380.47%504.74K
-48.76%10.99K
-95.45%1.21K
18.81%19.87K
Net income
1.23%-20.16M
-20.42%-4.54M
-17.81%-5.28M
28.66%-5.81M
-12.85%-4.53M
8.34%-20.41M
20.23%-3.77M
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
Net income continuous Operations
1.23%-20.16M
-20.42%-4.54M
-17.81%-5.28M
28.66%-5.81M
-12.85%-4.53M
8.34%-20.41M
20.23%-3.77M
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
Minority interest income
Net income attributable to the parent company
1.23%-20.16M
-20.42%-4.54M
-17.81%-5.28M
28.66%-5.81M
-12.85%-4.53M
8.34%-20.41M
20.23%-3.77M
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.23%-20.16M
-20.42%-4.54M
-17.81%-5.28M
28.66%-5.81M
-12.85%-4.53M
8.34%-20.41M
20.23%-3.77M
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
Basic earnings per share
31.46%-0.61
0.00%-0.11
11.76%-0.15
54.76%-0.19
27.27%-0.16
47.95%-0.89
62.07%-0.11
54.05%-0.17
32.26%-0.42
48.84%-0.22
Diluted earnings per share
31.46%-0.61
0.00%-0.11
11.76%-0.15
54.76%-0.19
27.27%-0.16
47.95%-0.89
62.07%-0.11
54.05%-0.17
32.26%-0.42
48.84%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.06%18.71M34.07%4.47M7.33%4.79M-37.80%5.09M-0.19%4.37M-8.78%20.35M-24.42%3.33M-8.72%4.46M5.84%8.18M-17.17%4.38M
Selling and administrative expenses -11.11%8.5M0.59%2.12M5.39%1.94M-37.77%2.33M12.91%2.11M-11.38%9.56M3.59%2.11M-27.02%1.84M0.05%3.75M-24.98%1.87M
-General and administrative expense -11.11%8.5M0.59%2.12M5.39%1.94M-37.77%2.33M12.91%2.11M-11.38%9.56M3.59%2.11M-27.02%1.84M0.05%3.75M-24.98%1.87M
Research and development costs -5.36%10.21M91.65%2.35M8.69%2.85M-37.83%2.76M-9.97%2.26M-6.33%10.79M-48.41%1.22M10.74%2.62M11.28%4.44M-10.19%2.51M
Operating profit 8.06%-18.71M-34.07%-4.47M-7.33%-4.79M37.80%-5.09M0.19%-4.37M8.55%-20.35M24.42%-3.33M8.72%-4.46M-5.84%-8.18M16.29%-4.38M
Net non-operating interest income expense -31.56%244.39K60.71%83.34K-25.93%78.07K-49.64%42.57K-64.95%40.41K-27.75%357.1K-51.20%51.86K-0.56%105.41K-34.94%84.53K-24.16%115.3K
Non-operating interest income -31.56%244.39K-----------------27.75%357.1K----------------
Total other finance cost --------25.93%-78.07K49.64%-42.57K64.95%-40.41K--------0.56%-105.41K34.94%-84.53K24.16%-115.3K
Other net income (expense) -799.86%-833.67K-638.02%-84.78K77.40%-27.38K-1,324.92%-620.92K-137.52%-100.59K127.74%119.12K103.86%15.76K-247.37%-121.14K27.61%-43.58K725.73%268.08K
Gain on sale of security -799.86%-833.67K-638.02%-84.78K77.40%-27.38K-1,324.92%-620.92K-137.52%-100.59K127.74%119.12K103.86%15.76K-247.37%-121.14K27.61%-43.58K725.73%268.08K
Income before tax 2.89%-19.3M-36.89%-4.47M-5.82%-4.74M30.39%-5.67M-10.90%-4.43M10.43%-19.87M30.70%-3.26M4.73%-4.47M-6.27%-8.14M21.99%-3.99M
Income tax 60.41%861.12K-86.11%70.12K4,896.25%549.29K11,579.49%141.21K405.73%100.51K577.16%536.82K3,380.47%504.74K-48.76%10.99K-95.45%1.21K18.81%19.87K
Net income 1.23%-20.16M-20.42%-4.54M-17.81%-5.28M28.66%-5.81M-12.85%-4.53M8.34%-20.41M20.23%-3.77M4.93%-4.49M-5.92%-8.14M21.86%-4.01M
Net income continuous Operations 1.23%-20.16M-20.42%-4.54M-17.81%-5.28M28.66%-5.81M-12.85%-4.53M8.34%-20.41M20.23%-3.77M4.93%-4.49M-5.92%-8.14M21.86%-4.01M
Minority interest income
Net income attributable to the parent company 1.23%-20.16M-20.42%-4.54M-17.81%-5.28M28.66%-5.81M-12.85%-4.53M8.34%-20.41M20.23%-3.77M4.93%-4.49M-5.92%-8.14M21.86%-4.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.23%-20.16M-20.42%-4.54M-17.81%-5.28M28.66%-5.81M-12.85%-4.53M8.34%-20.41M20.23%-3.77M4.93%-4.49M-5.92%-8.14M21.86%-4.01M
Basic earnings per share 31.46%-0.610.00%-0.1111.76%-0.1554.76%-0.1927.27%-0.1647.95%-0.8962.07%-0.1154.05%-0.1732.26%-0.4248.84%-0.22
Diluted earnings per share 31.46%-0.610.00%-0.1111.76%-0.1554.76%-0.1927.27%-0.1647.95%-0.8962.07%-0.1154.05%-0.1732.26%-0.4248.84%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -